期刊文献+

HGF,uPA在脑胶质瘤中的表达及意义 被引量:3

Expression and significance of hepatocyte growth factor and urokinase-type plasminogen activator in glioma cells
暂未订购
导出
摘要 目的:探讨肝细胞生长因子(HGF)和尿激酶型纤溶酶原激活剂(uPA)在人脑胶质瘤细胞中的表达及与胶质瘤生物学行为的关系。方法:免疫组织化学SABC方法检测HGF、uPA的表达。结果:8例正常脑组织HGF、uPA表达阴性;62例脑胶质瘤组织中,随病理分级的增加,HGF、uPA表达增加,差别十分显著(P<0.01)。结论:HGF,uPA的表达可能在促进脑胶质瘤的细胞增殖、恶性演变和侵袭过程中起重要作用。 Objective: To examine the expressions of hepatocyte growth factor (HGF) and urokinase-type plasminogen activator (uPA) in human glioma cells as well as their relationship with the biological behavior of glioma. Methods: An immunohistochemistry method, SABC, was used to measure the expression levels of HGF and uPA. Results: No expression was found in the 8 cases of normal brain tissue. However, the expressions of HGF and uPA in gliomas were parallel to the grades of gliomas. Significant difference was found between low-grade gliomas and high-grade gliomas (P<(0.01).) Conclusion:The HGF and uPA may play an important role in the development and invasion of glioma cells.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2005年第3期251-252,共2页 Journal of China Medical University
关键词 脑胶质瘤 病理分级 侵袭性 肝细胞生长因子 尿激酶型纤溶酶原激活剂 glioma pathological grade invasion hepatocyte growth factor urokinase-type plasminogen activator
  • 相关文献

参考文献4

  • 1Moriyama T, Kataoka H, Hamasuna R, et al. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells[ J ]. Clin Exp Metastasis, 1999,17 (10) : 873 - 879.
  • 2步星耀,章翔,陈恩志,刘先珍,梁景文,易声禹.尿激酶型纤溶酶原激活因子基因与胶质瘤的侵袭及预后的关系[J].肿瘤,1999,19(4):223-225. 被引量:3
  • 3Yamamoto M, Sawaya R, Mohanam S,et al. Expression and localization of urokinase-type plasminogen activaor receptor in human gliomas[J]. Cancer Res, 1994,54(8) : 5016-5020.
  • 4Webb CP, Hose CD, Koochekpour S, et al. The geldanamycines are potent inhibitor of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network[J]. Cancer Res, 2000, 60(2) : 342 - 349.

二级参考文献4

  • 1步星耀 金百祥 等.nm23-H1 mRNA表达与肾母细胞瘤临床行为的关系[J].中国肿瘤临床,1997,24:179-179.
  • 2Chen Z Q,Cancer,1997年,57卷,20页
  • 3步星耀,中国肿瘤临床,1997年,24卷,179页
  • 4Maeda K,Br J Cancer,1995年,72卷,319页

共引文献2

同被引文献24

  • 1陈谦学,张化明,杨海,吴立权,王军民,邹志鹏,张华.白细胞介素6、信号传导和转录活化因子3和血管内皮生长因子在人脑胶质瘤中的表达及相关性研究[J].中华实验外科杂志,2006,23(12):1457-1459. 被引量:16
  • 2Aguilar S,Nye E,Chan J,et al.Murine but not humanmesenchymal stem cells generate osteosarcoma-like lesionsin the lung[J].Stem Cells,2007,25:1586-1594.
  • 3Morrison SJ,Spradling AC.Stem cells and niches:mecha-nisms that promote stem cell maintenance throughout life[J].Cell,2008,132:598-611.
  • 4Zhao M,Gao FH,Wang JY,et al.JAK2/STAT3 signalingpathway activation mediates tumor angiogenesis by upregula-tion of VEGF and bFGF in non-small-cell lung cancer[J].Lung Cancer,2011,73:366-374.
  • 5Liu Y,Lin J.Blocking the IL-6-STAT3 signaling pathway:potential liver cancer therapy[J].Future Oncol,2011,7:161-164.
  • 6Li H,Fan X,Houghton J.Tumor microenvironment:therole of the tumor stroma in cancer[J].J Cell Biochem,2007,101:805-815.
  • 7Kirkpatrick CJ,Fuchs S,Unger RE.Co-culture systemsfor vascularization-learning from nature[J].Adv Drug De-liv Rev,2011,63:291-299.
  • 8Ito M,Barys L,O'Reilly T,et al.Comprehensive map-ping of p53 pathway alterations reveals an apparent role forboth SNP309 and MDM2 amplification in sarcomagenesis[J].Clin Cancer Res,2011,17:416-426.
  • 9Slack A, Shohet JM. MDM2 as a critical effector of the MYCN oncogene in tumorigenesis [ J ]. Cell Cycle,2005, 4 : 857 - 860.
  • 10Mild C, Inoue Y, Hiro J, et al. Combined measurement of hepato- cyte growth factor and carcinoembryonic antigen as a prognostic- marker for patients with dukes A and B colorectal cancer. Results of a five-year study [J]. Dis Colon Rectum, 2006, 49(11): 1710-1718.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部